Eric Ende is joining the Matinas BioPharma Holdings Inc. board April 3.
Ende is the president of Ende BioMedical Consulting Group.
Discover more about S&P Global’s offerings
Matinas BioPharma appoints director
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy
Eric Ende is joining the Matinas BioPharma Holdings Inc. board April 3.
Ende is the president of Ende BioMedical Consulting Group.